These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18784433)
1. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker. Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Müller HM; Widschwendter A; Fiegl H; Ivarsson L; Goebel G; Perkmann E; Marth C; Widschwendter M Cancer Res; 2003 Nov; 63(22):7641-5. PubMed ID: 14633683 [TBL] [Abstract][Full Text] [Related]
3. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Hu XC; Wong IH; Chow LW Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527 [TBL] [Abstract][Full Text] [Related]
6. Prognostic DNA methylation marker in serum of cancer patients. Müller HM; Fiegl H; Widschwendter A; Widschwendter M Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938 [TBL] [Abstract][Full Text] [Related]
7. Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue. Bhavani V; Srinivasulu M; Ahuja YR; Hasan Q Cancer Biomark; 2009; 5(4):207-13. PubMed ID: 19729830 [TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681 [TBL] [Abstract][Full Text] [Related]
9. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406 [TBL] [Abstract][Full Text] [Related]
10. BRCA1 in non-inherited breast carcinomas (Review). Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of BRCA1 and p16 gene methylation in sporadic breast cancer]. Feng J; Hu LH; Lu J; Li YR; Xie F Ai Zheng; 2009 Apr; 28(4):436-40. PubMed ID: 19622308 [TBL] [Abstract][Full Text] [Related]
12. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients. Jing F; Zhang J; Tao J; Zhou Y; Jun L; Tang X; Wang Y; Hai H Onkologie; 2007 Feb; 30(1-2):14-9. PubMed ID: 17264521 [TBL] [Abstract][Full Text] [Related]
14. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557 [TBL] [Abstract][Full Text] [Related]
15. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa. Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187 [TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Bean GR; Ibarra Drendall C; Goldenberg VK; Baker JC; Troch MM; Paisie C; Wilke LG; Yee L; Marcom PK; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Scott V; Seewaldt VL Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):50-6. PubMed ID: 17220331 [TBL] [Abstract][Full Text] [Related]
18. Haplo-insufficiency of BRCA1 in sporadic breast cancer. Staff S; Isola J; Tanner M Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823 [TBL] [Abstract][Full Text] [Related]
19. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls. Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population. Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]